135 assets in Type 2 Diabetes Mellitus

Cagrisema

Clenbuterol

L-Acetyl Carnitine

ck-0045

Dobesilic Acid

Eloralintide

Epigallocatechin-3-Gallate

gl0034

ht-6184

hu6

Human Faecal Matter

Macupatide

mk-6240

mkp10241

pg-102

Polyene Phosphatidyl Choline

Tangningtongluo Tablets

tg103

Tipelukast

Gsbr-1290

nnc0519-0130

Celecoxib

Glycerin,Anhydrous

L-Prolinamide, N-(19-Carboxy-1-Oxononadecyl)-L-?-Glutamyl-L-Arginyl-L-?-Aspartylglycyl-L-Threonyl-L-Alanyl-L-Threonyl-L-Lysyl-L-Alanyl-L-Threonyl-L-?-Glutamyl-L-Arginyl-L-Leucyl-L-Alanyl-5-Carboxy-L-Norvalyl-L-Phenylalanyl-L-Leucyl-L-Glutaminyl-L-Arginyl-L-Seryl-L-Seryl-L-Phenylalanyl-N-Methylglycyl-L-Alanyl-N-Methyl-L-Isoleucyl-L-Leucyl-L-Seryl-L-Seryl-L-Threonyl-L-?-Glutamyl-L-Valylglycyl-L-Seryl-L-Asparaginyl-L-Threonyl-4-Hydroxy-, (3?8)-Lactam, (4R)-

ly6249492

Nisostirotide

Valsartan

Iohexol

k-757

K-833

Sodium P-Aminohippurate

Gip

Aln-4324

Aln-Khk

Exenatide [Bydureon]

hec88473

azd5004

bgm0504

Ecnoglutide

pf-06954522

t2026

Aro-Alk7

Dynamos

Ent-03

Exendin-4 Fc Fusion Protein

Immunoglobulin G1-Kappa, Anti-[Homo Sapiens Mstn (Myostatin, Growth Differentiation Factor 8, Gdf8, Gdf-8) Latent Myostatin Complex], Humanized Monoclonal Antibody;

Niacin

qx1206

ct-996

Glucagon-Like Peptide 1, Human